Research.  Information.  Education.


Parents Against Pharmaceutical Abuse (PAPA) continuously monitors reports and painstakingly probes records to collect and analyze data relating to the homicidal risk of psychotropic medications.  Leveraging advanced search, virtualization, social networking, and data mining technologies enables PAPA to identify emerging trends and patterns that have long eluded more traditional and outmoded methods of drug risk assessment.


Once our in-depth research identifies relevant data acquisition candidates, PAPA submits public information requests to obtain records from international, federal, state, and local entities.  When needed, PAPA litigates to secure public access to unlawfully withheld records.  The resulting 360-degree view of drug risk information fosters increased consumer awareness, and more informed personal health and public policy decision-making.


Through MurderMeds.com, Pharmabuse.com, social and traditional media, PAPA endeavors to better educate the public, health care providers, journalists, and officials alike of the homicidal risk of psychotropic medications. According to the American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-5), “Between 7 percent and 25 percent of individuals presenting with a first episode of psychosis in different settings are reported to have substance/medication-induced psychotic disorder.”

PAPA is sustained through the generous support of parents who believe children, adolescents, and young adults can and do thrive without pharmacologically altered brain chemistry, and who want to end the modern epidemic of medication-induced psychosis and violence.

WARNING: Before starting or stopping psychotropic medications, consult your health care provider.